Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain - PubMed (original) (raw)

Review

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

R B Darnell. Proc Natl Acad Sci U S A. 1996.

Abstract

Paraneoplastic neurologic disorders (PNDs) are believed to be autoimmune neuronal degenerations that develop in some patients with systemic cancer. A series of genes encoding previously undiscovered neuronal proteins have been cloned using antiserum from PND patients. Identification of these onconeural antigens suggests a reclassification of the disorders into four groups: those in which neuromuscular junction proteins, nerve terminal/vesicle-associated proteins, neuronal RNA binding proteins, or neuronal signal-transduction proteins serve as target antigens. This review considers insights into basic neurobiology, tumor immunology, and autoimmune neuronal degeneration offered by the characterization of the onconeural antigens.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1981 Aug 1;2(8240):224-6 - PubMed
    1. Nature. 1982 Jul 15;298(5871):240-4 - PubMed
    1. Nature. 1983 Jul 14-20;304(5922):129-35 - PubMed
    1. Neurology. 1984 Apr;34(4):480-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7636-40 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources